Covered recipient · General Payments record
HAL S SHIMAZU
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$9,030.49
- Reported across 489 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $241.61 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $55.11 | 3 |
| Novo Nordisk AS | $37.41 | 2 |
| Lilly USA, LLC | $27.79 | 1 |
| ABBVIE INC. | $27.12 | 1 |
| ABIOMED | $22.36 | 1 |
| Merck Sharp & Dohme Corporation | $20.05 | 1 |
| Amgen Inc. | $20.00 | 1 |
| PFIZER INC. | $16.36 | 1 |
| Edwards Lifesciences Corporation | $15.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.12 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106088168 | CMS |
| ABIOMED | $22.36 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142258126 | CMS |
| Amgen Inc. | $20.00 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111706418 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.54 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105653412 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.23 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105572625 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.34 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104247785 | CMS |
| Edwards Lifesciences Corporation | $15.41 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138886427 | CMS |
| Lilly USA, LLC | $27.79 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134994728 | CMS |
| Merck Sharp & Dohme LLC | $20.05 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141856980 | CMS |
| Novo Nordisk Inc | $15.60 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096881300 | CMS |
| Novo Nordisk Inc | $21.81 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096602669 | CMS |
| PFIZER INC. | $16.36 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131156059 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.